Follow-The-Filings

Security · featured owners

RCKT Rocket Pharmaceuticals Inc.

COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 0.3%
  • $17M
  • 2 add

Who owns this now

Largest portfolio weights among featured holders · max 0.3% (James Silverman - Opaleye...) · not free-float ownership

  1. James Silverman add 0.31%
  2. Lee Ainslie add 0.12%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Lee Ainslie - Maverick Capital 2026 Q2 0.12% Add +10.0% 3,923,963 $13M history
James Silverman - Opaleye Management 2026 Q2 0.31% Add +4.7% 1,000,000 $3M history

2 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $0.00 $0.00 $0.00
Net income -$245.6M -$258.75M -$223.12M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $378.22M $378.18M $192.73M
Total non-current assets * $188.12M $149.52M $137.72M
Total assets $566.34M $527.7M $330.45M
Total current liabilities $48.5M $40.68M $30.21M
Total non-current liabilities * $25.26M $23.78M $23.02M
Total equity $492.57M $463.23M $277.22M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$194.92M -$209.72M -$190.01M
Cash from investing -$98.07M $131.71M $103.77M
Cash from financing $208.4M $185.74M $148,000
Net change in cash * -$84.58M $107.72M -$86.1M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders